Dr. Walovitch is Chief Scientific Officer of Voiant, which he joined as Chief Medical Officer in January 2009. Prior to joining Voiant, he served as the Senior Vice President of clinical research at Acusphere, Inc., Vice President of Preclinical and Clinical Research at Epix Medical, and held various positions as Research Pharmacologist and Project Clinician in the Imaging Agent Group at the DuPont Merck Pharmaceutical Company. He completed his postdoctoral fellowship at the National Institute on Drug Abuse’s Addiction Research Center in the Neurochemistry section. Dr. Walovitch has a Doctorate in Pharmacology from the University of Illinois Medical Center and a Bachelor’s degree in Biology from the University of Illinois. He is an author of more than 100 peer-reviewed publications, mostly in the field of medical imaging.